• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Register
RxHarun
Login / Register Login/Signup
  • Health (A – Z)
  • Drugs (A – Z)
  • Rx Cancer (A – Z)
  • Rx Neurology (A – Z)
  • Rx Urology
  • Rx Lab Test (A – Z)
  • Rx Shop (A – Z)
  • Rx iT World
  • Rx Foundation

Ketoconazole; Uses, Dosage, Side Effects, Interactions, Pregnancy

3 Views
Drugs (A - Z)
  • Mechanism of Action of Ketoconazole
  •  Indications of Ketoconazole
  • Therapeutic Indications
  • Contraindications of Ketoconazole
  • Dosage of Ketoconazole
  • Side Effects of Ketoconazole
  • Interactions of Ketoconazole
  • Pregnancy & Lactation

Ketoconazole is a synthetic derivative of phenylpiperazine with broad antifungal properties and potential antineoplastic activity. Ketoconazole inhibits sterol 14-a-dimethylase, a microsomal cytochrome P450-dependent enzyme, thereby disrupting the synthesis of ergosterol, an important component of the fungal cell wall. (NCI04)

Ketoconazole is an imidazole fungicidal agent with a very broad spectrum of activity against many fungal species that is used for the treatment of superficial and systemic fungal infections. Ketoconazole is a well-documented cause of clinically apparent acute drug-induced liver injury and is no longer recommended as a first line antifungal agent.
Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Ketoconazole is sold commercially as a tablet for oral administration (although this use has been discontinued in a number of countries), and in a variety of formulations for topical administration, such as creams (used to treat tinea; cutaneous candidiasis, including candidal paronychia; and pityriasis versicolor) and shampoos (used primarily to treat dandruff—seborrhoeic dermatitis of the scalp) .

Mechanism of Action of Ketoconazole

Ketoconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary for the conversion of lanosterol to ergosterol. This results in inhibition of ergosterol synthesis and increased fungal cellular permeability. Other mechanisms may involve the inhibition of endogenous respiration, interaction with membrane phospholipids, inhibition of yeast transformation to mycelial forms, inhibition of purine uptake, and impairment of triglyceride and/or phospholipid biosynthesis. Ketoconazole can also inhibit the synthesis of thromboxane and sterols such as aldosterone, cortisol, and testosterone.

 Indications of Ketoconazole

  • Blastomycosis
  • Candidiasis, Cutaneous
  • Candiduria
  • Chromomycosis
  • Coccidioidomycosis
  • Dandruff
  • Histoplasmosis
  • Oral candida
  • Paracoccidioidomycosis
  • Pityriasis Versicolor
  • Seborrheic dermatitis
  • Tinea corporis
  • Tinea cruris
  • Tinea pedis
  • Recalcitrant cutaneous dermatophyte infection
  • Severe cutaneous dermatophyte infection
  • Chronic mucocutaneous candidiasis
  • Dermatophytosis
  • Esophageal candidiasis
  • Onychomycosis, Fingernail
  • Onychomycosis, toenail
  • Oral thrush
  • Paracoccidioidomycosis
  • Tinea corporis
  • Tinea versicolor
  • Vaginal yeast infection

Therapeutic Indications

  • For the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis.
  • Treatment of Cushing’s syndrome
  • Treatment of granulosa cell tumors
  • Ketoconazole HRA is indicated for the treatment of endogenous Cushing’s syndrome in adults and adolescents above the age of 12 years.

Contraindications of Ketoconazole

  • Have known hypersensitivity to other azole medicines such as ketoconazole;
  • Are taking terfenadine, if 400 mg per day multidose of fluconazole is administered;
  • Concomitant administration of ketoconazole and quinidine, especially when ketoconazole is administered in high dosages;
  • Take SSRIs such as fluoxetine or sertraline.

Dosage of Ketoconazole

Strengths:

Tablets: 200 mg; Shampoo: 1% and 2%; Cream: 2%, Gel: 2%, Foam: 2%

Blastomycosis

  • Initial dose: 200 mg orally once a day
  • If clinical responsiveness insufficient within expected time: Dose may be increased to 400 mg orally once a day.
  • Duration of therapy: 6 months (usual duration for systemic infection)

Chromomycosis

  • Initial dose: 200 mg orally once a day
  • If clinical responsiveness insufficient within expected time: Dose may be increased to 400 mg orally once a day.

Coccidioidomycosis

  • Initial dose: 200 mg orally once a day
  • If clinical responsiveness insufficient within expected time: Dose may be increased to 400 mg orally once a day.
  • Duration of therapy: 6 months (usual duration for systemic infection)

Histoplasmosis

  • Initial dose: 200 mg orally once a day
  • If clinical responsiveness insufficient within expected time: Dose may be increased to 400 mg orally once a day.
  • Duration of therapy: 6 months (usual duration for systemic infection)

Blastomycosis

  • 2 years or older: 3.3 to 6.6 mg/kg orally once a day
  • Duration of therapy: 6 months (usual duration for systemic infection)

Chromomycosis

  • 2 years or older: 3.3 to 6.6 mg/kg orally once a day
  • Duration of therapy: 6 months (usual duration for systemic infection)

Coccidioidomycosis

  • 2 years or older: 3.3 to 6.6 mg/kg orally once a day
  • Duration of therapy: 6 months (usual duration for systemic infection)

Paracoccidioidomycosis

  • 2 years or older: 3.3 to 6.6 mg/kg orally once a day
  • Duration of therapy: 6 months (usual duration for systemic infection)

Side Effects of Ketoconazole

The most common 

  • Abdominal or stomach pain
  • feeling of heaviness, pain, warmth and/or swelling in a leg or in the pelvis
  • sudden tingling or coldness in an arm or leg
  • Nausea
  • liver problems,
  • stomach pain,
  • vomiting,
  • Dizziness
  • Burning, itching, stinging, redness, or other sign of irritation at the application site, rash
  • a headache,
  • increased intracranial pressure,
  • meningeal signs,
  • reversible hair loss or thinning, and
  • fever.

Common

  • chills or fever
  • a headache, severe and throbbing
  • joint or back pain
  • muscle aching or cramping
  • muscle pains or stiffness
  • chest pressure or squeezing pain in chest
  • discomfort in arms, shoulders, neck or upper back
  • excessive sweating
  • sudden slow or difficult speech
  • sudden drowsiness or need to sleep
  • fast breathing
  • sharp pain when taking a deep breath
  • fast or slow heartbeat
  • coughing up blood
  • rust colored urine
  • liver problems–nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes)
  • decreased amount of urine

Rare

  • Anxiety
  • change in vision
  • chest pain or tightness
  • confusion
  • cough
  • Agitation
  • arm, back, or jaw pain
  • blurred vision
  • chest pain or discomfort
  • convulsions
  • extra heartbeats
  • fainting
  • hallucinations
  • headache
  • irritability
  • lightheadedness
  • mood or mental changes
  • muscle pain or cramps
  • muscle spasm or jerking of all extremities
  • burning,
  • stinging,
  • severe pain in your upper stomach spreading to your back, nausea and vomiting;
  • signs of congestive heart failure–shortness of breath (even with mild exertion), cough with mucus, fast heartbeats, swelling, rapid weight gain, sleep problems; or.

Interactions of Ketoconazole

Kitoconazole may interact with following drugs ,supplyments & may change the efficacy of drugs

  • medications that use the enzyme  such as budesonide , cyclosporine , darifenacin , dihydroergotamine , fentanyl pimozide , quinidine , sirolimus , tacrolimus , terfenadine , fluticasone , eletriptan , lovastatin  quetiapine, sildenafil , and simvastatin 
  • medications that block the enzyme CYP3A4 such as some macrolide antibiotics (clarithromycin, telithromycin), some HIV protease inhibitors (indinavir, nelfinavir, ritonavir, saquinavir), some HCV protease inhibitors (boceprevir, telaprevir), some azole antifungals (ketoconazole, itraconazole, posaconazole, voriconazole), conivaptan, delavirdine, and nefazodone
  • medications that increase the activity of the enzyme CYP3A4 such as carbamazepine , phenobarbital, phenytoin , rifampin  and nimodipine
  • methylprednisolone
  • midazolam 
  • triazolam
  • digoxin
  • warfarin 
  • phenytoin 
  • rifampin
  • alcohol

Interactions that can make your drugs less effective

When ketoconazole is less effective: When ketoconazole is used with certain drugs, it may not work as well to treat your condition. This is because the amount of ketoconazole in your body may be decreased. Examples of these drugs include:

  • Ranitidine, famotidine, cimetidine, pantoprazole, omeprazole, and rabeprazole. You should take ketoconazole with an acidic beverage, such as a non-diet soda, if you take these drugs together.
  • Aluminum hydroxide. You should take this drug 1 hour before or 2 hours after taking ketoconazole.
  • Antibiotics, such as isoniazid and rifabutin
  • Anticonvulsants, such as carbamazepine and phenytoin
  • Antivirals, such as efavirenz and nevirapine
  • Carbamazepine. Your doctor may monitor your carbamazepine levels.

Pregnancy & Lactation

FDA Pregnancy category C 

Ketoconazole falls into category C. In animal studies, pregnant animals were given this medication and had some babies born with problems. There are no well-controlled studies that have been done in humans with ketoconazole, though. Therefore, this medication may be used if the potential benefits to the mother outweigh the potential risks to the unborn child.

Lactation

It is not known if ketoconazole crosses into human milk. Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using ketoconazole.

References

  • DrugBank

    http://www.drugbank.ca/drugs/DB01026
    http://www.drugbank.ca/drugs/DB01026#targets
    http://www.drugbank.ca/drugs/DB01026#enzymes
    http://www.drugbank.ca/drugs/DB01026#transporters

    https://www.webmd.com/drugs/2/drug-11593/ketoconazole-oral/details

    https://www.drugs.com/mtm/ketoconazole.html

  • EPA DSStox

    https://comptox.epa.gov/dashboard/dsstoxdb/results?search=DTXSID7029879

  • European Chemicals Agency (ECHA)

    https://echa.europa.eu/substance-information/-/substanceinfo/100.059.680

    https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/34735

    https://www.webmd.com/drugs/2/drug-11593/ketoconazole-oral/details/list-contraindications

  • ILO-ICSC

    http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&p_card_id=1700

  • The National Institute for Occupational Safety and Health (NIOSH)

    https://www.cdc.gov/niosh-rtecs/TK78BB6C.html

  • ClinicalTrials.gov

    https://clinicaltrials.gov/

  • DailyMed

    h.gov/dailymed/search.cfm?labeltype=all&query=KETOCONAZOLE

  • LiverTox

    https://livertox.nlm.nih.gov/Ketoconazole.htm

  • NCIt

    https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C605

  • EU Community Register of Medicinal Products

    https://ec.europa.eu/health/documents/community-register/html/o965.htm

    https://ec.europa.eu/health/documents/community-register/html/h965.htm

    https://ec.europa.eu/health/documents/community-register/html/o1857.htm

    https://ec.europa.eu/health/documents/community-register/html/o1031.htm

    https://ec.europa.eu/health/documents/community-register/html/ho25029.htm

  • HSDB

    https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+65277-42-1

  • WHO ATC

    https://www.whocc.no/atc/

    https://www.whocc.no/atc_ddd_index/

  • EU REGULATION (EC) No 1272/2008

    http://ec.europa.eu/growth/sectors/chemicals/classification-labelling/index_en.htm

  • Safe Work Australia – HCIS

    http://hcis.safeworkaustralia.gov.au/HazardousChemical/Details?chemicalID=2715

  • FDA Medication Guides

    https://www.fda.gov/downloads/Drugs/DrugSafety/UCM362592.pdf

  • FDA Orange Book

    https://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm

  • MassBank of North America (MoNA)

    http://mona.fiehnlab.ucdavis.edu/spectra/browse?inchikey=XMAYWYJOQHXEEK-OZXSUGGESA-N

  • PD

    http://www.rcsb.org/ligand/KKK

  • PubMed Health

    http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010826/

    http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0001018/

    http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010827/

  • Springer NatureRead more …
  • The Cambridge Structural Database

    http://www.ccdc.cam.ac.uk/pages/Home.aspx

  • Wikipedia

    https://www.wikidata.org/wiki/Q27121163

    https://en.wikipedia.org/wiki/Ketoconazole

    https://pubchem.ncbi.nlm.nih.gov

Ketoconazole

SaveSavedRemoved 0
Ketoconazole; Uses, Dosage, Side Effects, Interactions, Pregnancy
Previous

Fluconazole; Uses, Dosage, Side Effects, Interactions, Pragnancy

Ketoconazole; Uses, Dosage, Side Effects, Interactions, Pregnancy
Next

Itraconazole; Uses, Dosage, Side Effects, Interactions, Pragnancy

Related Articles
Added to wishlistRemoved from wishlist 0
Vasodilator Drugs

Vasodilator Drugs

Added to wishlistRemoved from wishlist 0
Methamphetamine

Methamphetamine Hydrochloride – Uses, Dosage, Side Effects, Interaction

Added to wishlistRemoved from wishlist 0
Methamphetamine – Uses, Dosage, Side Effects, Interactions

Methamphetamine – Uses, Dosage, Side Effects, Interactions

Added to wishlistRemoved from wishlist 0
Vitamin D3 – Uses, Dosage, Side Effects, Interactions

Vitamin D3 – Uses, Dosage, Side Effects, Interactions

      RxHarun
      Logo
      Register New Account
      Already have an account? Login
      Log In
      Lost Password?
      Don't have an account? Sign Up

      RxHarun

      AI Chat Bot

      Dorian

      Hey, how can I help you today?

      Powered by Elementor

      Click to start chat